Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HIV / AIDS specialty page provides HIV/AIDS-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HIV / AIDS NEWS - Page 11

Altered Broadly Neutralizing HIV Antibody Potential Major Player in HIV Prevention
NIAID Vaccine Research Center scientists alters broadly neutralizing HIV antibody to make it last longer in the blood.
For Infectious Disease Physicians, A Busy Career Comes With Added Responsibility
Infectious disease physicians often have to fight to garner the attention of policymakers.
Top 5 Infectious Disease News of the Week—February 18, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
FDA Warns of Potential Long-Term Risks Of Clarithromycin in Patients with Heart Disease
FDA recommends that health care providers practice caution before prescribing clarithromycin to patients with heart disease due to potentially fatal long-term risks.
With PrEP, Daily Dosing May Not Be Necessary
PrEP does not have to be taken daily to be effective, but consistency and a strong support system are key.
Cannabis Use May Reduce HIV-Associated Inflammation & Immune Activation In ART-Treated Patients
A recent study finds a potential link between cannabis use and possible beneficial reduction in systemic inflammation and immune activation in ART-treated HIV patients.
Once-Daily Fixed-Dose HIV Combo Drug from Mylan NV Receives Tentative Approval from FDA
Mylan NV's new drug application for its combo regimen of dolutegravir, emtricitabine, and tenofovir alafenamide, received tentative approval from the US Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR).
About Half of Millennials Are Not Getting Tested For HIV
A recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.
Big advances in treatment can